Boston, MA -- (SBWIRE) -- 08/20/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Tilly's Inc (NYSE:TLYS), Office Depot Inc (NYSE:ODP), Eaton Vance Limited Duration Income Fund (NYSEMKT:EVV), PDL BioPharma Inc. (NASDAQ:PDLI)
Tilly's Inc (NYSE:TLYS) stock gained 0.90% to $13.42. The company announced that the company will release its financial results for the second quarter ended August 3, 2013, after the market close on Wednesday, August 28, 2013. Daniel Griesemer, President and Chief Executive Officer, and Bill Langsdorf, Senior Vice President and Chief Financial Officer, will host a conference call that afternoon (August 28, 2013) at 4:30 p.m. ET (1:30 p.m. PT) to discuss the financial results.
How Should Investors Trade TLYS After The Recent Volatility? Get Free Report Her e
Office Depot Inc (NYSE:ODP) shares increased 0.96% to $4.19. The company on August 20 announced that negotiations it initiated to reach a good-faith compromise with its largest shareholder, Starboard Value LP (together with its affiliates, "Starboard"), ahead of the Company's Annual Meeting of Shareholders on August 21, have not resulted in an agreement.
Additionally, the company, on August 19, announced the next phase of its multi-faceted anti-bullying partnership with One Direction - a new Office Depot Foundation educational program intended to help stop bullying.
How Should Investors Trade ODP After The Recent Volatility? Get Free Report Here
Eaton Vance Limited Duration Income Fund (NYSEMKT:EVV) shares climbed 0.55% to $14.58 in the early hour. EVV on August 15 announced the earnings of the Fund for the three months ended June 30, 2013. The Fund's fiscal year ends on March 31, 2014. For the three months ended June 30, 2013, the Fund had net investment income of $29,029,427 ($0.247 per common share). From this amount, the Fund paid dividends on preferred shares of $87,688 (equal to $0.001 for each common share), resulting in net investment income after the preferred dividends of $28,941,739 or $0.246 per common share.
Is EVV A Good Buy After The Recent Price Movement? Find Out Here
PDL BioPharma Inc. (NASDAQ:PDLI) stock is trading at $7.89. The company on August 8 reported financial results for the second quarter and six months ended June 30, 2013. Royalty revenues for the second quarter of 2013 increased 14 percent to $143.6 millionfrom $125.9 millionreported in the second quarter of 2012. Net income for the second quarter of 2013 was $93.7 million, or $0.62per diluted share, as compared with net income of $73.5 million, or $0.52per diluted share, in the same quarter of 2012.
Is PDLI A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)